Pediatric and Ambulatory Research in Infectious Diseases
NCT ID: NCT04471493
Last Updated: 2024-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
400000 participants
OBSERVATIONAL
2017-06-26
2030-08-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Carriage of Streptococcus Pneumoniae in Infants With Acute Otitis Media and in Infants Attending Day-care Centers
NCT02888457
Clinical Features, Outcome and Prognosis of Human Metapneumovirus (hMPV) Lower Respiratory Tract Infections in Adult Inpatients
NCT03460171
Advanced Diagnostics for Enhanced QUality of Antibiotic Prescription in Respiratory Tract Infections in Emergency Rooms
NCT04781530
FebriDx® Pediatric Validation Study
NCT07211997
Virus Interactions in the Respiratory Tract; a Cohort Study With Children
NCT05318235
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pharyngitis
* otitis
* pneumonia
* influenza
* bronchiolitisz
* varicella
* gastroenteritis
* enterovirus disease
* bordetella pertussis disease
* using the same same software, Axi5-Infansoft (developed by CompuGroup Medical, Nanterre, France)
Exclusion Criteria
1 Day
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AFPA (Association Française de Pédiatrie Ambulatoire)
UNKNOWN
GlaxoSmithKline
INDUSTRY
Sanofi
INDUSTRY
Pfizer
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY
Association Clinique Thérapeutique Infantile du val de Marne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Cohen
Role: STUDY_DIRECTOR
Association Clinique et Thérapeutique Infantile du Val de Marne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AFPA
Créteil, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Cohen R, Bechet S, Gelbert N, Frandji B, Vie Le Sage F, Thiebault G, Kochert F, Cahn-Sellem F, Werner A, Ouldali N, Levy C. New Approach to the Surveillance of Pediatric Infectious Diseases From Ambulatory Pediatricians in the Digital Era. Pediatr Infect Dis J. 2021 Jul 1;40(7):674-680. doi: 10.1097/INF.0000000000003116.
Related Links
Access external resources that provide additional context or updates about the study.
New Approach to the Surveillance of Pediatric Infectious Diseases From Ambulatory Pediatricians in the Digital Era
Trends in pediatric ambulatory community acquired infections before and during COVID-19 pandemic: A prospective multicentric surveillance study in France
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACT0116
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.